PMC:7252009 / 1700-2425 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"38","span":{"begin":111,"end":119},"obj":"Species"},{"id":"39","span":{"begin":0,"end":12},"obj":"Disease"},{"id":"40","span":{"begin":14,"end":37},"obj":"Disease"},{"id":"41","span":{"begin":39,"end":59},"obj":"Disease"},{"id":"42","span":{"begin":65,"end":73},"obj":"Disease"},{"id":"43","span":{"begin":124,"end":128},"obj":"Disease"},{"id":"44","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"45","span":{"begin":163,"end":172},"obj":"Disease"},{"id":"46","span":{"begin":207,"end":215},"obj":"Disease"},{"id":"47","span":{"begin":264,"end":272},"obj":"Disease"},{"id":"48","span":{"begin":579,"end":588},"obj":"Disease"},{"id":"49","span":{"begin":716,"end":724},"obj":"Disease"}],"attributes":[{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:9606"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:D006973"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:D002318"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D006937"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D003920"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D003643"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:C000657245"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D003643"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C000657245"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:C000657245"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"MESH:D003643"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Hypertension, cardiovascular diseases, hypercholesterolemia, and diabetes are the most common comorbidities in patients who died from COVID-19.5 Consequently, the mortality rate (6.4%) of confirmed cases of COVID-19 in Brazil, within 52 days from the beginning of COVID-19 in every country, is around twice that of other countries, like Germany and Canada (3.0% and 4.1%, respectively), where the primary health care system is more effective in providing primary care.6, 7, 8 Thus, countries that have greater control over chronic health conditions may consequently have a lower mortality rate, with a population in better health being an important benefit in pandemic situations like the one we are witnessing with COVID-19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":0,"end":37},"obj":"Disease"},{"id":"T13","span":{"begin":0,"end":12},"obj":"Disease"},{"id":"T14","span":{"begin":14,"end":37},"obj":"Disease"},{"id":"T15","span":{"begin":65,"end":73},"obj":"Disease"},{"id":"T16","span":{"begin":207,"end":215},"obj":"Disease"},{"id":"T17","span":{"begin":264,"end":272},"obj":"Disease"},{"id":"T18","span":{"begin":716,"end":724},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0001302"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Hypertension, cardiovascular diseases, hypercholesterolemia, and diabetes are the most common comorbidities in patients who died from COVID-19.5 Consequently, the mortality rate (6.4%) of confirmed cases of COVID-19 in Brazil, within 52 days from the beginning of COVID-19 in every country, is around twice that of other countries, like Germany and Canada (3.0% and 4.1%, respectively), where the primary health care system is more effective in providing primary care.6, 7, 8 Thus, countries that have greater control over chronic health conditions may consequently have a lower mortality rate, with a population in better health being an important benefit in pandemic situations like the one we are witnessing with COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":234,"end":236},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T9","span":{"begin":571,"end":572},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T10","span":{"begin":600,"end":601},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Hypertension, cardiovascular diseases, hypercholesterolemia, and diabetes are the most common comorbidities in patients who died from COVID-19.5 Consequently, the mortality rate (6.4%) of confirmed cases of COVID-19 in Brazil, within 52 days from the beginning of COVID-19 in every country, is around twice that of other countries, like Germany and Canada (3.0% and 4.1%, respectively), where the primary health care system is more effective in providing primary care.6, 7, 8 Thus, countries that have greater control over chronic health conditions may consequently have a lower mortality rate, with a population in better health being an important benefit in pandemic situations like the one we are witnessing with COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":0,"end":725},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hypertension, cardiovascular diseases, hypercholesterolemia, and diabetes are the most common comorbidities in patients who died from COVID-19.5 Consequently, the mortality rate (6.4%) of confirmed cases of COVID-19 in Brazil, within 52 days from the beginning of COVID-19 in every country, is around twice that of other countries, like Germany and Canada (3.0% and 4.1%, respectively), where the primary health care system is more effective in providing primary care.6, 7, 8 Thus, countries that have greater control over chronic health conditions may consequently have a lower mortality rate, with a population in better health being an important benefit in pandemic situations like the one we are witnessing with COVID-19."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":0,"end":12},"obj":"Phenotype"},{"id":"T4","span":{"begin":14,"end":37},"obj":"Phenotype"},{"id":"T5","span":{"begin":39,"end":59},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0003124"}],"text":"Hypertension, cardiovascular diseases, hypercholesterolemia, and diabetes are the most common comorbidities in patients who died from COVID-19.5 Consequently, the mortality rate (6.4%) of confirmed cases of COVID-19 in Brazil, within 52 days from the beginning of COVID-19 in every country, is around twice that of other countries, like Germany and Canada (3.0% and 4.1%, respectively), where the primary health care system is more effective in providing primary care.6, 7, 8 Thus, countries that have greater control over chronic health conditions may consequently have a lower mortality rate, with a population in better health being an important benefit in pandemic situations like the one we are witnessing with COVID-19."}